Related Experiment Video
Updated: Jun 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Plasmalogen levels in full-term neonates
I Labadaridis1, M Moraitou, M Theodoraki
1NICU, General Hospital Nikea, Piraeus, Athens, Greece.
Neonates have significantly lower red blood cell plasmalogen levels compared to older children. This finding suggests a need for distinct normal values for diagnosing peroxisomal disorders in newborns, who may be more susceptible to oxidative stress.
Area of Science:
- Biochemistry
- Cell Biology
- Neonatal Medicine
Background:
- Plasmalogens are vital phospholipids with a unique vinyl ether bond, abundant in the nervous system and muscles.
- They play key roles in protecting against oxidative stress, myelin formation, and signal transduction.
- Red blood cell (RBC) plasmalogen levels are crucial biomarkers for diagnosing peroxisomal disorders.
Purpose of the Study:
- To investigate and establish normal ranges for RBC plasmalogen levels in neonates.
- To compare neonatal plasmalogen levels with those of older children.
- To inform diagnostic criteria for peroxisomal diseases in newborns.
Main Methods:
- Studied 25 healthy, full-term neonates within their first five days of life.
- Quantified RBC plasmalogens using gas chromatography.
- Compared findings with 15 healthy children aged 1-8 years.
Main Results:
- Neonates exhibited statistically significant lower plasmalogen levels compared to the control group of older children.
- This indicates a developmental difference in plasmalogen concentration from birth.
Conclusions:
- Established lower normal plasmalogen levels for neonates are necessary for accurate peroxisomal disease diagnosis.
- Lower neonatal plasmalogen levels may increase vulnerability to oxidative stress.
- Further research into plasmalogen function and metabolism in neonates is warranted.
More Related Videos
07:26Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
Published on: January 26, 2019
08:08Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution